COMPANY
HBVtech
Timeline
- Grant Government grant — NIH R34: $258,750 (annual award, as published), announced Aug 27, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
- Grant Government grant — NIH N43: $606,178 (annual award, as published), announced Aug 1, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
- Grant Government grant: $4.73M (total, as published), announced Jul 1, 2025. Agency: DoD. Source: government award database. source ↗
Funding
- Government grant — NIH R34: $258,750 (annual award, as published), announced Aug 27, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
- Government grant — NIH N43: $606,178 (annual award, as published), announced Aug 1, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
- Government grant: $4.73M (total, as published), announced Jul 1, 2025. Agency: DoD. Source: government award database. source ↗
NIH awards 5
- NIH contract (government contract; not a grant and not an investment round) 75N93022C00042-P00002-9999-1 FY2023: $50,000 awarded for that fiscal year; activity N01 (OTHER_NIH); PI ZHANG, YANG-YUAN; recipient as written: HBVTECH, Rockville, MD. ANTIVIRAL DRUGS source ↗
- NIH contract (government contract; not a grant and not an investment round) 75N93022C00042-0-9999-1 FY2022: $1,499,999 awarded for that fiscal year; activity N01 (OTHER_NIH); PI ZHANG, YANG-YUAN; recipient as written: HBVTECH, Rockville, MD. ANTIVIRAL DRUGS TO source ↗
- NIH award 1R43AI155066-01A1 FY2021: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI ZHANG, YONG-YUAN; recipient as written: HBVTECH, Rockville, MD. A New HBV Drug For Establishing Durable Antiviral Eff source ↗
- NIH contract (government contract; not a grant and not an investment round) 75N93020C00045-P00001-9999-1 FY2021: $6,500 awarded for that fiscal year; activity N43 (OTHER_NIH); PI ZHANG, YONG-YUAN; recipient as written: HBVTECH, Rockville, MD. Development of a source ↗
- NIH contract (government contract; not a grant and not an investment round) 75N93020C00045-0-9999-1 FY2020: $299,868 awarded for that fiscal year; activity N43 (OTHER_NIH); PI ZHANG, YONG-YUAN; recipient as written: HBVTECH, Rockville, MD. Development of a Nov source ↗